Metagenomic Sequencing Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Metagenomic Sequencing Industry Market Size Be by 2025?
There has been a rapid expansion in the metagenomic sequencing market size recently. The market, which will rise from $2.13 billion in 2024 to $2.5 billion in 2025, is set to experience a Compound Annual Growth Rate (CAGR) of 17.5%. The substantial growth witnessed during the historical period can be credited to the intensified participation of the government, increasing count of metagenome sequencing research studies, widened use of metagenomics in genomic research and diagnostic investigations, availability of funding for research, and the progression in Next Generation Sequencing (NGS) data analysis tools.

What's the Long-Term Growth Forecast for the Metagenomic Sequencing Market Size Through 2029?
The market size for metagenomic sequencing is predicted to experience a swift expansion in the upcoming years, reaching $4.71 billion in 2029 with a compound annual growth rate (CAGR) of 17.1%. This predicted progression during the forecast period is due to various factors such as reduced computational expenses, an increased emphasis on identifying new biomolecules of interest, a surge in the implementation of high-throughput sequencing technologies, a high demand for personalized medication and disease detection. Additionally, a rise in the occurrence of infectious diseases can be identified as a contributing factor. The forecast period is expected to witness major trends such as cutting-edge technology innovations, metagenomics' application of sophisticated genomic technologies, increased allocation for R&D, advancements in the field of sequencing technology, and the analysis of NGS data via big data.

View the full report here:
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

What Are the Key Growth Drivers Fueling the Metagenomic Sequencing Market Expansion?
The rise in infectious diseases is set to catalyze the expansion of the metagenomic sequencing market. Such diseases occur due to harmful microorganisms like viruses, bacteria, parasites, or fungi and can transmit from one person to another directly or indirectly. Conditions weakening the immune system, including HIV/AIDS, cancer treatments, and autoimmune disorders, can heighten a person's vulnerability to these infectious diseases. Metagenomic sequencing presents a robust and adaptable method to research infectious diseases, offering invaluable information on pathogen diversity, transmission patterns, antimicrobial resistance, and outbreak tracking. As an illustration, the Government of Canada reported in January 2023 that 135 rabies samples were submitted in October 2022 and 159 were submitted in November 2022. Additionally, in March 2023, the Centers for Disease Control and Prevention, a US government institution, revealed a 5.9% increase in tuberculosis cases in the US, surging from 7,874 in 2021 to 8,331 in 2022. Thus, the escalating prevalence of infectious diseases fuels the growth of the metagenomic sequencing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

What Are the Key Trends Driving Metagenomic Sequencing Market Growth?
There is a significant emphasis by key players operating in the metagenomic sequencing market on the innovation of sequencing services to boost accuracy, throughput, and cost-effectiveness. In the realm of these advanced sequencing services are revolutionary genomic technologies that allow for the sequencing of larger DNA fragments, providing a more holistic snapshot of genetic structures than the conventional short-read methods. For example, in April 2024, a biotechnology firm based in Denmark, Clinical Microbiomics A/S, introduced superior long-read sequencing services. This encompasses 16S, ITS, 18S rRNA, customized gene sequencing, and extensive genomics and metagenomics, all contributing towards unrivaled resolution and quality in microbial scrutiny. This allows for profound insights into microbial communities and assists in generating top-notch metagenome-assembled genomes.

How Is the Metagenomic Sequencing Market Segmented?
The metagenomic sequencing market covered in this report is segmented -

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions
2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics
3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Subsegments:
1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)
2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments
3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing
4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16117&type=smp

Which Companies Are Leading the Charge in Metagenomic Sequencing Market Innovation?
Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

Which Regions Are Leading the Global Metagenomic Sequencing Market in Revenue?
North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16117

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.